PETKANAS DEAN (Chief Executive Officer) sold 0.7% of their position (180K shares) of NEUROPATHIX, INC. on the open market
Open‑market sale worth $4.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 6/2/2022ACC: 0001607062-22-000403
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-180K
Net shares
Net seller
$4.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
180K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−100K
Price / share
$0.03
Trade value
$2.60K
% of position
0.4%
5/26/2022
24.06M→23.96M
Common Stock
Direct
Shares
−50K
Price / share
$0.03
Trade value
$1.45K
% of position
0.2%
5/27/2022
23.96M→23.91M
Common Stock
Direct
Shares
−10K
Price / share
$0.03
Trade value
$280.00
% of position
0.0%
5/31/2022
23.91M→23.90M
Common Stock
Direct
Shares
−20K
Price / share
$0.03
Trade value
$520.00
% of position
0.1%
5/31/2022
23.90M→23.88M
Total
Net shares
−180K
Net value
-$4.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2022 | S · Sale | −100K | $0.03 | $2.60K | 0.4% | 24.06M | 23.96M |
| Common Stock Direct | 5/27/2022 | S · Sale | −50K | $0.03 | $1.45K | 0.2% | 23.96M | 23.91M |
| Common Stock Direct | 5/31/2022 | S · Sale | −10K | $0.03 | $280.00 | 0.0% | 23.91M | 23.90M |
| Common Stock Direct | 5/31/2022 | S · Sale | −20K | $0.03 | $520.00 | 0.1% | 23.90M | 23.88M |
| Total | −180K | -$4.85K | ||||||
Derivative Transactions0
No derivative transactions reported